Implementing these programs under Africa CDC leadership will enhance disease surveillance systems, expand laboratory infrastructure, and foster deeper partnerships with leading European research institutions.
The contract includes multiyear options that could ultimately deliver up to USD 482 million if exercised, enabling Shionogi to establish a dedicated manufacturing facility in the United States.
BioNTech’s decision follows a comprehensive strategic review aimed at aligning the company’s manufacturing capacity with its clinical pipeline and long-term business direction
The two companies began collaborating in 2024 through an option and license agreement valued at up to USD 465 million, which granted Gilead access to Tubulis’ proprietary ADC platforms.
When combined with a reduced-calorie diet and regular physical activity, Foundayo helps patients shed excess weight and maintain their progress.
The collaboration targets two key challenges with MSD’s existing Zaire Ebola vaccine: complex manufacturing requirements and the need for ultra-cold storage.
Pamba brings to the role a rich combination of frontline medical experience, executive leadership, and a proven track record of driving healthcare access across Africa.
The Houston subsidiary will now serve as the strategic headquarters, overseeing and expanding collaborations with medical institutions and pharmaceutical companies across the United States.
Beyond the initial payment, Centessa shareholders are set to receive an extra USD9 per share in contingent value rights (CVR), which could increase the total deal value by USD1.5 billion.
Central to this deal is TSND-201, also known as methylone, Transcend’s lead experimental drug for post-traumatic stress disorder (PTSD) and other psychiatric conditions.